DHTKD1 and neoplasm: In vitro studies in various cell lines have demonstrated that the replication of Ad-hTERTp-E1A, a CRAD that E1A driven by the hTERT promoter, is primarily restricted to telomerase-positive tumor cells, whereas no oncolytic activity is observed in normal primary fibroblasts and epithelial cells.